`Case: 1:16-cv—00651 Document #: 47-2 Filed: 11/08/16 Page 1 of 10 PagelD #:2003
`
`EXHIBIT 2
`
`EXHIBIT 2
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 2 of 10 PageID #:2004
`
`NOT FOR PUBLICATION
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`HOSPIRA, INC., et al.
`
`CIVIL ACTION NO. 09-4591
`
`(MLC)
`
`DRAFT MARKMAN OPINION
`
`Plaintiffs,
`
`v.
`
`SANDOZ,
`
`INC., et al.
`
`Defendants.
`
`COOPER, District Judge
`
`The Court's Draft Construction of the Term "Intensive Care"
`
`Although the parties used the term "intensive care" in two
`
`definitions under United States Patent No. 6,716,867 ("the '867
`
`Patent"), they did not define it.
`
`(See id. at 4 ("The parties do
`
`not dispute the construction of any terms of the Patents-In-
`
`Suit.").) Because the Court has determined that it must define
`
`this term before resolving the Motions, it will now construe it.
`
`The Court begins by noting the "'heavy presumption' "that a
`
`claim term carries its ordinary and customary meaning." CCS
`
`Fitness Inc. v. Brunswick Corp., 288 F.3d 1359, 1366 (Fed. Cir.
`
`2002). The ordinary and customary meaning of a claim term is the
`
`meaning a "person of ordinary skill in the art in question" (a
`
`"POSITA") would assign such term on the patent's priority date.
`
`Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. 2005). A
`
`POSITA is deemed to interpret the claim term in the context of
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 3 of 10 PageID #:2005
`
`the entire patent, including the specification.
`
`Id. Claims
`
`terms carry their ordinary and customary meanings unless
`
`otherwise indicated in the patent specification or file history.
`
`Wolverine Worldwide, Inc. v. Nike, Inc., 38 F.3d 1192, 1196 (Fed.
`
`Cir. 1994).
`
`"To ascertain the scope and meaning of the asserted claims,
`
`we look to the words of the claims themselves, the specification,
`
`the prosecution history, and any relevant extrinsic evidence.ff
`
`'
`Retractable Techs., Inc. v. Becton, Dicksinon & Co., 653 F.3d
`
`1296, 1303 (Fed. Cir. 2011), rehearing and rehearing en bane
`
`denied, 659 F.3d 1369. The Court first looks to the intrinsic
`
`evidence of record, which includes the patent's claims,
`
`specification, and complete prosecution history. Markman, 52
`
`F.3d at 979. Such intrinsic evidence is the most significant
`
`source of the legally operative meaning of disputed claim
`
`language. Vitronic Corp. v. Conceptronic, Inc., 90 F.3d 1576,
`
`1583 (Fed. Cir. 1996). The specification is "always highly
`
`relevant to the claim construction analysis" and is "the single
`
`best guide to the meaning of a disputed term.ff Honeywell Int'l,
`
`Inc. v. ITT Indus., Inc., 452 F.3d 1312, 1318 (Fed. Cir. 2006)
`
`(internal quotation marks omitted) . The specification may
`
`contain an intentional disclaimer or a disavowal of claim scope
`
`by the inventor, whereby the inventor's intention, expressed in
`
`the specification, is dispositive. Phillips, 415 F.3d at 1316.
`
`2
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 4 of 10 PageID #:2006
`
`It is, however, improper to read a limitation from the
`
`specification into the claims. Teleflex, Inc. v. Ficosa N. Am.
`
`Corp., 299 F.3d 1313, 1326 (Fed. Cir. 2002).
`
`In some instances, the ordinary meaning of claim language,
`
`as understood by a POSITA, will be readily apparent to the Court
`
`after reviewing the intrinsic evidence.
`
`In such instances, claim
`
`construction will involve simply applying the widely accepted
`
`meanings of commonly understood words. Phillips, 415 F.3d at
`
`1314.
`
`In other circumstances, however, the Court may consider
`
`extrinsic evidence, such as "expert and inventor testimony,
`
`dictionaries, and learned treatises."
`
`Id.
`
`In general, such
`
`evidence is less reliable than its intrinsic counterparts.
`
`Id.
`
`at 1318. Notably, "heavy reliance on the dictionary divorced
`
`from the intrinsic evidence risks transforming the meaning of the
`
`claim term to the artisan into the meaning of the term in the
`
`abstract, out of its particular context, which is the
`
`specification."
`
`Id. at 1321. Further, unsupported assertions by
`
`experts as to the definition of a claim term are not useful, and
`
`the after-the-fact testimony of the inventor is accorded little
`
`if any weight in the claim construction inquiry.
`
`Id. at 1318.
`
`The term that actually appears in the '867 Patent claims is
`
`"intensive care unit." The parties have stipulated that an
`
`"intensive care unit" is "any setting that provides intensive
`
`care", but failed to define "intensive care".
`
`3
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 5 of 10 PageID #:2007
`
`The Court begins its claim construction inquiry by examining
`
`the intrinsic evidence of record. While the '867 Patent claims
`
`and related prosecution history do not help to define "intensive
`
`care", the'867 Patent specification provides some guidance.
`
`In
`
`the specification, Plaintiffs repeatedly refer to sedating
`
`patients that suffer from "critical illness" and sedating
`
`"critically ill patients".
`
`(See, e.g., '867 Patent at col. 1 at
`
`32, 43.)
`
`In Example 3, the specification details sixteen cases
`
`of sedation of "critically ill patients", describing Phase III
`
`trials of dexmedetomidine and "the benefits of dexmedetomidine
`
`sedation in critically ill patients."
`
`(Id. at col. 8 at line 47
`
`- col. 13 at line 54.) The specification provides that each of
`
`the sixteen "critically ill" patients was admitted to an "ICU",
`
`i.e., an intensive care unit, either preoperatively or
`
`postoperatively, and underwent some form of surgery.
`
`The
`
`specification does not, however, disclose whether these patients
`
`underwent surgery because they were "critically ill" or whether
`
`they were considered"critically ill" because they underwent
`
`surgery.
`
`It also fails to disclose the type of nursing care
`
`provided to these patients or, more generally, the quality of
`
`perioperative care provided, except inasmuch as it discloses the
`
`administration of dexmedetomidine, analgesics, and other
`
`sedatives.
`
`(Id.)
`
`4
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 6 of 10 PageID #:2008
`
`Because examination of the intrinsic evidence does not
`
`render a clear definition of "intensive care", the Court next
`
`turns to extrinsic evidence. During discovery, the parties
`
`solicited deposition regarding the definition of "intensive
`
`care". Romeo Bachand, one of the named inventors of the '867
`
`Patent, testified that "intensive care is a unit or a place where
`
`people get total care, human care, not procedural care."
`
`(Dkt.
`
`entry no. 229-12, Bachand Dep. at 164.) He explained that
`
`"intensive care[,] by its meaning in the [1990s]
`
`. had to do
`
`with care, and the care was with generally the ratio of patients
`
`to nurses taking care of the total patient."
`
`(Id. at 162.)
`
`Bachand further explained that preoperative and postoperative
`
`surgical care are more closely related to the underlying surgical
`
`procedure than to intensive care.
`
`(Id. at 163.)
`
`Plaintiffs' expert witness, Michael Ramsey, M.D., testified
`
`that a "setting that provides intensive care" "would be an area
`
`where the patient is intensively monitored for a period of time
`
`until the condition that had taken the patient to that unit had
`
`resolved or the need for intensive care monitoring, intensive
`
`monitoring had passed."
`
`(Dkt. entry no. 229-7, Ramsay Dep. at
`
`64.) Ramsay defined "intensive monitoring" as "[o]ne-on-one or
`
`two-to-one nursing care, continual monitoring of vital signs,
`
`immediate availability of support systems."
`
`(Id. at 65.) He
`
`testified that a patient could receive such monitoring in many
`
`5
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 7 of 10 PageID #:2009
`
`areas of a hospital, including an intensive care unit, an
`
`operating room, or a postoperative recovery area.
`
`(Id. at 67-68;
`
`dkt. entry no. 229-8, Ramsey Dep. II at 209-10.)
`
`The Sandoz Companies' expert witness, Jesse B. Hall, M.D.,
`
`opined that critical care settings are defined more so "by the
`
`nature of the patient than by the label over the geographic
`
`location in the hospital."
`
`(Dkt. entry no. 228-2, Ex. E, Hall
`
`Dep. at 24.) He stated:
`
`[I]f a patient is critically ill and is in the
`emergency department but must wait six hours for a bed
`to be available, we don't say they are denied critical
`care management while they're in the emergency room.
`The facility can be turned to that purpose for that
`patient's needs.
`The same thing occurs in the recovery room when
`there isn't an ICU bed or perhaps the ICUs need to be
`decompressed.
`It's common to just change the nursing
`ratios to make the circumstance of adequate critical
`care environment because the physicians can go there as
`needed, and the monitoring equipment exists to ahieve
`the same endpoints.
`It becomes a nursing coverage
`issue more than anything else.
`
`(Id. at 22.) Hall clarified that patients could thus receive
`
`intensive care in emergency rooms and postoperative recovery
`
`rooms.
`
`(Id. at 23.)
`
`The Court also sua sponte reviewed information provided by
`
`dictionaries and treatises. The Court, specifically, reviewed
`
`information in THE MERCK M.11.NUAL or D.::AGNosrs AND T:~::.:ATMSNT, 19th ed.
`
`("The Merck Manual") and STt:DMM1's Mr:1ncA1 01CTlONAtn ("Stedman's").
`
`The Merck Manual does not provide an explicit definition of
`
`6
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 8 of 10 PageID #:2010
`
`"intensive care"; indeed, the index entry for "intensive care"
`
`states only "see Critically ill patient".
`
`T:-i:!: M;:::r<.c:<: MA:.JJAL or
`
`DIAGNOSIS A:w TRE:ATME:NT 364 0 (Robert S. Porter, MD, et al. eds., 19th
`
`ed., 2011). The main entry for that section, i.e., "Critical
`
`Care Medicine", provides:
`
`Critical care medicine specializes in caring for
`the most seriously ill patients. These patients are
`best treated in an ICU staffed by experienced
`personnel.
`ICUs have a high nurse:patient ratio
`to provide the necessary high intensity of service,
`including treatment and monitoring of physiologic
`parameters.
`Supportive care for the ICU patient includes
`provision of adequate nutrition and prevention of
`infection, stress ulcers and gastritis, and pulmonary
`embolism. Because 15 to 25% of patients admitted to
`the ICUs die there, physicians should know how to
`minimize suffering help dying patients maintain
`dignity.
`
`Id. at 2243-44. The rest of that section sets forth the methods
`
`for procedures used to monitor and treat critically ill patients.
`
`See id. at 2243-2302.
`
`Stedman's defines "intensive care" as "management and care
`
`of critically ill patients".
`
`STSDMAN' s MED.::CAL D1CTIONAT£ 315 (28th
`
`ed., 2006).
`
`It defines "critical" as "[d)enoting a morbid
`
`condition in which death is possible."
`
`Id. at 462.
`
`It also
`
`defines an "intensive care unit" as "a hospital facility for
`
`provision of intensive nursing and medical care of critically ill
`
`patients, characterized by the high quality and quantity of
`
`continuous nursing and medical supervision and by use of
`
`7
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 9 of 10 PageID #:2011
`
`sophisticated monitoring and resuscitative equipment".
`
`Id. at
`
`2067 (emphasis added).
`
`Upon consideration of this evidence, and placing
`
`considerable weight on the intrinsic evidence, i.e., on the
`
`specification of the '867 Patent, the Court has determined that
`
`the term "intensive care" has two important aspects. First,
`
`First, "intensive care" involves "critically ill", patients.
`
`(See '867 Patent, col. 1 at line 32, 43, col. 8 at line 47 - col.
`
`13 at line 54). See also M.sH.cK MA:-1uA1 Or' D1AGNos1s A:m Tt<.±::ATMJ::Nr 2243-
`
`44; STED:1JAN'S MEDICAL DICI'lO>JARY 315, 462, 2067. Such "critically
`
`ill" patients are typically "the most seriously ill patients" who
`
`undergo surgery or other major medical procedures.
`
`(See '867
`
`Patent, col. 8 at line 47 - col. 13 at line 54). See also
`
`STSDMAN'S MEDICAL DICTlONM<Y 315, 462. These patients may die,
`
`either as a result of underlying medical conditions or as a
`
`result of the treatment for those conditions.
`
`(See '867 Patent,
`
`col. 8 at line 47 - col. 13 at line 54). See also STEDMAN' s
`
`MEDICAL 02:CTIONA!<.Y 315, 462.
`
`Second, intensive care is characterized by ongoing medical
`
`supervision. MERC:<: MANUAL OF' DIAGNos=s AND TREAT'.'IENT 2243-44. Such
`
`supervision typically includes a high nurse-to-patient ratio and
`
`continuous nursing care.
`
`(Bachand Dep. at 162-64; Hall Dep. at
`
`22-23 (noting that intensive care is characterized as "a nursing
`
`coverage issue more than anything else.") . ) See also MERC:« MANUAL
`
`8
`
`
`
`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 10 of 10 PageID #:2012
`
`OF DIAGNOSIS AND T:<.:::ATMENT 2243. This supervision generally includes
`
`monitoring.
`
`Id.
`
`The Court will thus construe the term "intensive care" as
`
`follows:
`
`care provided to critically ill patients, typically
`characterized by high nursing-to-patient ratios,
`continuous medical supervision, and continuous
`monitoring.
`
`[DRAFT - NOT SIGNED]
`
`MARY L. COOPER
`United States District Judge
`
`9
`
`